These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9276529)

  • 21. Differential mRNA levels of c-myc, c-fos and MHC class I in several clones of a murine fibrosarcoma.
    Gaforio JJ; Pérez M; Algarra I; Mialdea MJ; Ljunggren HG; Garrido F
    Int J Cancer; 1991 Dec; 49(6):906-10. PubMed ID: 1959995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH
    Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.
    Romero I; Martinez M; Garrido C; Collado A; Algarra I; Garrido F; Garcia-Lora AM
    J Pathol; 2012 Jul; 227(3):367-79. PubMed ID: 22451343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
    Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cloned class I MHC-restricted, CD8+ anti-Meth A cytotoxic T-lymphocytes: recognition of an epitope derived from the Meth A gp110 tumor rejection antigen.
    Fassanito MA; Loftus D; De Leo RM; Law LW; Appella E; De Leo AB
    Cancer Res; 1994 Aug; 54(16):4424-9. PubMed ID: 7519121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus.
    Kimura T; Griffin DE
    J Virol; 2000 Jul; 74(13):6117-25. PubMed ID: 10846095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
    J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
    Cohen PA; Cohen PJ; Rosenberg SA; Mulé JJ
    Cancer Res; 1994 Feb; 54(4):1055-8. PubMed ID: 7906197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia.
    Ito A; Shinkai M; Honda H; Wakabayashi T; Yoshida J; Kobayashi T
    Cancer Immunol Immunother; 2001 Dec; 50(10):515-22. PubMed ID: 11776373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow-derived cells present MHC class I-restricted tumour antigens in priming of antitumour immune responses.
    Huang AY; Golumbek P; Ahmadzadeh M; Jaffee E; Pardoll D; Levitsky H
    Ciba Found Symp; 1994; 187():229-40; discussion 240-4. PubMed ID: 7796673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct patterns of expression of MHC class I and beta 2-microglobulin transcripts at early stages of mouse development.
    Jaffe L; Robertson EJ; Bikoff EK
    J Immunol; 1991 Oct; 147(8):2740-9. PubMed ID: 1918988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chaperone BAG6 is dispensable for MHC class I antigen processing and presentation.
    Bitzer A; Basler M; Groettrup M
    Mol Immunol; 2016 Jan; 69():99-105. PubMed ID: 26598275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
    Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.
    Twitty CG; Jensen SM; Hu HM; Fox BA
    Clin Cancer Res; 2011 Oct; 17(20):6467-81. PubMed ID: 21810919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
    Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
    Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice.
    Vertuani S; Triulzi C; Roos AK; Charo J; Norell H; Lemonnier F; Pisa P; Seliger B; Kiessling R
    Cancer Immunol Immunother; 2009 May; 58(5):653-64. PubMed ID: 18820911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.